Continuous Glucose Monitoring for Colorectal Cancer (CGM-CRC)
Continuous Glucose Monitoring, Colorectal Cancer
About this trial
This is an interventional supportive care trial for Continuous Glucose Monitoring focused on measuring cgm, Colorectal Cancer, continuous glucose monitoring
Eligibility Criteria
Inclusion Criteria: written informed consent confirmed colorectal cancer qualified for surgery Exclusion Criteria: patients who will be unable or will refuse to express informed concern pregnant women people undergoing dialysis treatment
Sites / Locations
- UCC Division of Oncological, Transplant and General SurgeryRecruiting
Arms of the Study
Arm 1
Experimental
Experimental
Study subjects submitted to the General Surgery Clinic for colorectal surgery. On admission day, patients will have a CGM sensor placed on the outer part of the upper arm. Patients will undergo standard surgical procedures and perioperative care. Glycemia will be continuously monitored for 10 days. The CGM sensor will be taken off during visit in Outpatient Clinic.